Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel-interacting protein 1 (KCNIP1) is a cytosolic protein belonging to the neuronal calcium sensor (NCS) family of EF-hand calcium-binding proteins. It acts as a regulatory subunit for Kv4 (Shal-type) voltage-gated rapidly inactivating A-type potassium channels, modulating their channel density, inactivation kinetics, and recovery in a calcium-dependent, isoform-specific manner. KCNIP1 is crucial in controlling neuronal membrane excitability and may respond dynamically to changes in intracellular calcium. Alternative splicing produces multiple isoforms. Dysregulation or mutation of KCNIP1 has been associated with epilepsy and blood pressure abnormalities[1][2][3][7].
Modulates channel properties as a regulatory subunit (not a direct drug target; influences ion channel kinetics through protein-protein interaction)[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel-interacting protein 1 (KCNIP1).